彩虹集團(003023.SZ):泉源衞生已變更為公司持股100%的全資子公司
格隆匯6月30日丨彩虹集團(003023.SZ)公佈,此前披露,公司持有成都泉源衞生用品有限公司(“泉源衞生”)66%的股權,公司與日本阿斯製藥株式會社(“阿斯製藥”)、日本住商山美德化學株式會社(“住商山美德”)簽署《股權轉讓協議》,約定公司分別以人民幣4,007,326.90元、3,163,679.13元的價格受讓阿斯製藥、住商山美德所持泉源衞生19%與15%的股權。
上述股權轉讓變更登記、泉源衞生公司章程備案手續已辦理完畢,泉源衞生於近日取得成都市雙流區行政審批局換發的《營業執照》,企業類型由“有限責任公司(中外合資)”變更為“有限責任公司(非自然人投資或控股的法人獨資)”。泉源衞生已由公司持股66%變更為公司持股100%的全資子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.